Hot Keywords
Alzheimer Narcotics Imaging Leukemia Lymphedema Breast cancer Immunotherapy Ductal carcinoma Cancer prevention Crouzon syndrome Cardiovascular diseases Forensic odontology Platelet-derived vesicles Platelet aerobic metabolism Non-small cell lung cancer

Topic: Immunotherapy as a New Hope Against Solid Tumors

A special issue of Journal of Unexplored Medical Data

ISSN 2572-8180 (Online)

Submission deadline: 30 Jun 2018

Guest Editor(s)

  • Dr. Francesco Perri
    Department of Medical Oncology, S.G. Moscati Hospital of Taranto, Taranto, Italy.


Special Issue Introduction

The immune system is able to defend us against both pathogens and cancer.
Immune response against cancer cells is very complex, and it can be divided into three phases, such as: the innate immune response; the activation of specific T-cells against cancer and the killing of tumour cells made by the above mentioned T-cells.
On the basis of these findings, it is easy to understand that strengthen the immune response against tumour cells may be an incisive strategy of therapy.
Several immunotherapy approaches have been proposed over the years, however all of them have a common characteristic: the possibility to obtain a class of T-cytotoxic lymphocytes able to attack the tumor.
Immunotherapy strategies that have been developed over the years may be briefly divided in five categories: (1) direct administration of immunogenic tumour antigens; (2) providing DC pulsed with specific tumour antigens; (3) providing specific T-cells, pulsed with immunogenic tumour antigens; (4) administering cytokines able to activate T-cells against tumour cells; and (5) modifying the microenviromnent in which the T-cells mature, removing all the stimuli able to induce T-cells anergy.
The history of immunotherapy starts with the administration of prototypes of cancer vaccines, such as the Coley toxin and ends with the discover of the last generation checkpoint inhibitors.
Aim of our special issue is to review the importance and the clinical applications of several strategies of immunotherapy against solid tumors.


Immunotherapy, T-cells, solid tumors

Submission Deadline

30 Jun 2018

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 30 Jun 2018
Contacts: Ellian Huang, Managing Editor,

Published Articles

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties